| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/HEP.510280607 |
| P698 | PubMed publication ID | 9828211 |
| P2093 | author name string | Yamazaki M | |
| Kuriyama S | |||
| Fukui H | |||
| Nakatani T | |||
| Yoshiji H | |||
| Kikukawa M | |||
| Yoshii J | |||
| Tsujinoue H | |||
| P2860 | cites work | Tight control of gene expression in mammalian cells by tetracycline-responsive promoters | Q24564850 |
| Vascular endothelial growth factor is a secreted angiogenic mitogen | Q28646475 | ||
| Angiogenesis in cancer, vascular, rheumatoid and other disease | Q29547165 | ||
| Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo | Q29614729 | ||
| Vascular endothelial growth factor/vascular permeability factor is an autocrine growth factor for AIDS-Kaposi sarcoma | Q35967211 | ||
| Molecular cloning and adhesive properties of murine platelet/endothelial cell adhesion molecule 1. | Q36364434 | ||
| Suppression of glioblastoma angiogenicity and tumorigenicity by inhibition of endogenous expression of vascular endothelial growth factor | Q37408097 | ||
| Clinicopathologic features of encapsulated hepatocellular carcinoma.A study of 26 cases | Q40097688 | ||
| The implications of angiogenesis for the biology and therapy of cancer metastasis | Q40394139 | ||
| Vascular permeability factor (VPF, VEGF) in tumor biology | Q40801255 | ||
| Mammary carcinoma cells over-expressing tissue inhibitor of metalloproteinases-1 show enhanced vascular endothelial growth factor expression. | Q41071763 | ||
| Human hepatic myofibroblasts increase invasiveness of hepatocellular carcinoma cells: evidence for a role of hepatocyte growth factor | Q41077052 | ||
| Involvement of hepatocyte growth factor in increased integrin expression on HepG2 cells triggered by adhesion to endothelial cells | Q41142654 | ||
| Transformed cell lines susceptible or resistant to in vivo surveillance against tumorigenesis | Q41964840 | ||
| Hepatocyte growth factor-stimulated renal tubular mitogenesis: effects on expression of c-myc, c-fos, c-met, VEGF and the VHL tumour-suppressor and related genes | Q42858934 | ||
| Prognostic factors after hepatectomy for hepatocellular carcinomas. A univariate and multivariate analysis | Q44599071 | ||
| Construction of retroviral vectors to induce strong hepatoma cell-specific expression of cytokine genes | Q45880219 | ||
| Expression of vascular endothelial growth factor in normal liver and hepatocellular carcinoma: an immunohistochemical study. | Q50950759 | ||
| TUMOUR ANGIOGENESIS | Q58212404 | ||
| In Vivo Activation of met Tyrosine Kinase by Heterodimeric Hepatocyte Growth Factor Molecule Promotes Angiogenesis | Q58831780 | ||
| Vascular permeability factor, an endothelial cell mitogen related to PDGF | Q69116052 | ||
| Increased expressions of vascular endothelial growth factor and its receptors, flt-1 and KDR/flk-1, in regenerating rat liver | Q71530389 | ||
| Enhanced CD34 expression of sinusoid-like vascular endothelial cells in hepatocellular carcinoma | Q71774177 | ||
| Tissue-specific expression of HSV-tk gene can induce efficient antitumor effect and protective immunity to wild-type hepatocellular carcinoma | Q73316714 | ||
| Increased expression of vascular endothelial growth factor in human hepatocellular carcinoma | Q73908738 | ||
| Endothelial CD34 is suppressed in human malignancies: role of angiogenic factors | Q74164811 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hepatocellular carcinoma | Q1148337 |
| P304 | page(s) | 1489-1496 | |
| P577 | publication date | 1998-12-01 | |
| P1433 | published in | Hepatology | Q15724398 |
| P1476 | title | Vascular endothelial growth factor tightly regulates in vivo development of murine hepatocellular carcinoma cells | |
| P478 | volume | 28 |
| Q35701281 | Angiogenesis in hepatocellular carcinoma: the retrospectives and perspectives |
| Q42176947 | Angiopoietin 2 displays a vascular endothelial growth factor dependent synergistic effect in hepatocellular carcinoma development in mice. |
| Q41706847 | Chemotherapy for Hepatocellular Carcinoma: Current Evidence and Future Perspectives |
| Q34382605 | Clinical significance of the expression of isoform 165 vascular endothelial growth factor mRNA in noncancerous liver remnants of patients with hepatocellular carcinoma |
| Q79424117 | Cyclooxygenase-2 expression in hepatocellular carcinoma, cirrhosis and chronic hepatitis in the United States |
| Q57486613 | Disruption of PD-1 Enhanced the Anti-tumor Activity of Chimeric Antigen Receptor T Cells Against Hepatocellular Carcinoma |
| Q39647908 | Effects of the knockdown of hypoxia inducible factor-1α expression by adenovirus-mediated shRNA on angiogenesis and tumor growth in hepatocellular carcinoma cell lines. |
| Q74194209 | Endothelin-1 plays a major role in portal hypertension of biliary cirrhotic rats through endothelin receptor subtype B together with subtype A in vivo |
| Q38182833 | Exploration of liver cancer genomes |
| Q44927708 | Halting the interaction between vascular endothelial growth factor and its receptors attenuates liver carcinogenesis in mice. |
| Q35193283 | Hepatocellular carcinoma: are we making progress? |
| Q34409128 | Hepatocellular carcinoma: review of current treatment with a focus on targeted molecular therapies. |
| Q53490169 | Increased vascular endothelial growth factor transcription in residual hepatocellular carcinoma after open versus laparoscopic hepatectomy in a small animal model. |
| Q54789949 | Inhibition of breast carcinoma and trophoblast cell invasiveness by vascular endothelial growth factor. |
| Q49831580 | Inhibition of microRNA-19b promotes ovarian granulosa cell proliferation by targeting IGF-1 in polycystic ovary syndrome |
| Q27478238 | Insights into the Pathobiology of Hepatitis C Virus-Associated Cirrhosis |
| Q36474130 | Is the vascular endothelial growth factor messenger RNA expression in resectable hepatocellular carcinoma of prognostic value after resection? |
| Q73114513 | KDR/Flk-1 is a major regulator of vascular endothelial growth factor-induced tumor development and angiogenesis in murine hepatocellular carcinoma cells |
| Q45859491 | Liposome-mediated gene transfer of K1-5 suppresses tumor development and improves the prognosis of hepatocellular carcinoma in mice |
| Q34695180 | Liver cancer: Targeted future options |
| Q92952317 | MiR-204 suppresses cell proliferation and promotes apoptosis in ovarian granulosa cells via targeting TPT1 in polycystic ovary syndrome |
| Q35166808 | Molecular mechanisms of glioma invasiveness: the role of proteases |
| Q78357688 | Molecular pathogenesis of human hepatocellular carcinoma |
| Q81455649 | Prognostic factors and recurrence of small hepatocellular carcinoma after hepatic resection or microwave ablation: a retrospective study |
| Q36474101 | Prognostic significance of preoperative circulating vascular endothelial growth factor messenger RNA expression in resectable hepatocellular carcinoma: a prospective study |
| Q39696733 | Q39, a quinoxaline 1,4-Di-N-oxide derivative, inhibits hypoxia-inducible factor-1α expression and the Akt/mTOR/4E-BP1 signaling pathway in human hepatoma cells |
| Q34494774 | Role of vitamin K2 in preventing the recurrence of hepatocellular carcinoma after curative treatment: a meta-analysis of randomized controlled trials |
| Q35125781 | Sirolimus in liver transplantation |
| Q36708741 | Sorafenib: where do we go from here? |
| Q38114062 | Targeted therapies in the treatment of advanced hepatocellular carcinoma |
| Q35207561 | Targeted therapy in hepatocellular carcinoma |
| Q39904702 | Targeting heat-shock protein 90 improves efficacy of rapamycin in a model of hepatocellular carcinoma in mice |
| Q45387961 | The angiogenic and prognostic implications of VEGF, Ang-1, Ang-2, and MMP-9 for hepatocellular carcinoma with background of hepatitis B virus |
| Q37704703 | Transarterial sorafenib chemoembolization: preliminary study of technical feasibility in a rabbit model |
Search more.